Contract Service Directory

Biozone Laboratories, Inc.





Company Headquarters

580 Garcia Ave.
Pittsburg, CA 94565
United States

Contract Service Directory

    Related Content

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • cGMP Manufacture | Drug Delivery | Industry News
      Aptar Pharma Extends CR/SF Mfg. Capabilities in North America

      Aptar Pharma Extends CR/SF Mfg. Capabilities in North America

      Installs manufacturing capacity for Child-Resistant and Senior-Friendly Classic Nasal Pump at Congers, NY site
      06.08.17

    • Breaking News | Drug Delivery | Industry News | Inspections
      Tapemark Passes Regulatory Hurdle

      Tapemark Passes Regulatory Hurdle

      Manufacturing facility completes successful FDA pre-approval and general GMP inspection
      06.07.17


    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?
      06.06.17

    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported
      06.05.17

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
      Lonza Acquires PharmaCell

      Lonza Acquires PharmaCell

      Offers core expertise in autologous cell and gene therapy manufacturing
      06.05.17


    • Breaking News | Promotions & Moves
      Recipharm Makes Appointment in the UK & Ireland

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Industry News
      Kemwell Provides Services for U.S. Trial

      Kemwell Provides Services for U.S. Trial

      Supplies biologics drug substance for phase 1 clinical trials for U.S. IND filing
      05.18.17


    • Saneca Pharma Expands Services in Russia

      Receives confirmation of multi-dosage cGMP approval for Russia
      05.16.17

    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17

    • Breaking News | cGMP Manufacture | Industry News | Injectables | Parenterals | Solid Dosage/Creams/Ointments | Solid Dosage/Semi-solids
      Fresenius Kabi Acquires Akorn in $4.3bn Deal

      Fresenius Kabi Acquires Akorn in $4.3bn Deal

      Strategically complementary combination to enhance and diversify Fresenius Kabi’s business and portfolio
      04.26.17


    • Trump Picks New FDA Commish

      Combatting high drug prices and overregulation likely to be high on agenda
      Tim Wright, Editor 04.03.17

    • Aseptic Processing | Fill/Finish | Injectables | Vials
      Newsmakers: Peter Soelkner

      Newsmakers: Peter Soelkner

      A conversation with Peter Soelkner, managing director, Vetter Pharma International GmbH
      Tim Wright, Contract Pharma 04.03.17

    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Aseptic Processing | Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Inspections | Lyophilization

      LSNE Completes Two FDA Inspections

      FDA PAI and general GMP inspection of two aseptic manufacturing plants and QC laboratory completed successfully
      03.06.17

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

      Fujifilm Launches Bio CDMO Division

      Aiming to achieve 100 billion yen in revenue by FY2024/March
      03.02.17

    • QA/QC | Regulatory Affairs
      FDA’s Quality Agreements Guidance

      FDA’s Quality Agreements Guidance

      Evaluation of FDA’s recently issued Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
      Paul Mason, Ph.D., Director of Lachman Consultant Services, Inc. 01.26.17